League decision and oversight during Hurts’ treatment

The NFL will not discipline the Philadelphia Eagles for how the franchise handled quarterback Jalen Hurts’ medical situation, the league confirmed in a statement released Tuesday.
NFL officials said they had been in contact with Eagles medical personnel and with clinicians at the Cleveland Clinic in London throughout Hurts’ evaluation and treatment, NBC News reported. League representatives concluded the process that led to Hurts being cleared to play in Week 5 did not warrant punishment, and the franchise will not face discipline for the absence of an injury designation before that game.
Medical findings and roster consequences for Philadelphia

The medical picture for Hurts is serious and explicitly limits his availability. The Eagles and Hurts’ agent, Nicole Lynn, said Monday that the quarterback has deep vein thrombosis and bilateral pulmonary emboli. A blood clot in Hurts’ left calf traveled to his lungs, and he has been placed on injured reserve and is expected to miss the remainder of the season.
Hurts’ prescribed treatment is a regimen of blood thinners, and he will not be permitted to participate in any football activities while taking those medications. Hurts is on injured reserve and is expected to miss the rest of the season, leaving the Eagles to proceed without their starter.
What the NFL’s finding means for the Eagles and the league

The league’s decision resolves the immediate question of punishment and clears the Eagles of procedural violation in how Hurts was medically cleared for the London game against Jacksonville. Multiple reports, including coverage by Players, indicated the NFL determined the team did not violate its injury-reporting rules. The broader conclusion, as reported, was that the medical process “was handled appropriately.”
That determination reflects the NFL’s willingness to lean on medical consultations and to consider clinical input when controversies around player availability arise. League officials emphasized their involvement in monitoring Hurts’ care, which included ongoing communication with the Eagles’ medical staff and outside specialists in London.
For the Eagles, the ruling ends the regulatory side of the episode but not the operational one. With Hurts on injured reserve and sidelined for the season, Philadelphia must adjust its depth chart and offensive planning without the player who had been its starting quarterback. The team also must manage public and internal questions about player health protocols while maintaining treatment and recovery priorities for Hurts.
Clinical details and the timeline of escalation
The sequence that led to the current diagnosis began with a superficial vein thrombosis that was later found to have progressed. Follow-up imaging showed the development of deep vein thrombosis and blood clots in both lungs, a development teams and clinicians called significant enough to end Hurts’ season.
Because anticoagulant therapy is the standard management for clots of this nature, Hurts’ prescribed treatment with blood thinners creates an immediate and enforceable barrier to football activity: the bleeding risk associated with contact sports while on anticoagulation makes participation unsafe until those medications are discontinued and clinicians clear him to resume contact.
The league’s public statement that it had contact with clinicians in London and Eagles medical staff underscores the clinical complexity and cross-jurisdictional nature of Hurts’ care. That interaction — and the league’s ultimate decision not to impose discipline — frames how the NFL is balancing its regulatory role with deference to medical judgment in acute, rapidly evolving health situations.
As Philadelphia prepares to move forward without Hurts, the team and the league face overlapping priorities: the immediate competitive adjustments for the Eagles and the continued imperative to ensure player safety through transparent, medically grounded processes. The NFL’s ruling closes the disciplinary chapter, but the medical recovery and roster consequences for Hurts and the Eagles will define the remainder of the season.




